
H. Steven Moffic, MD, explores the role of gadflies in society, drawing inspiration from philosophy and current events to provoke meaningful change.

H. Steven Moffic, MD, explores the role of gadflies in society, drawing inspiration from philosophy and current events to provoke meaningful change.

Explore the evolving relationship between neurology and psychiatry, highlighting modern treatments that bridge the gap in understanding brain disorders.

Advanced imaging techniques enhance deep brain stimulation for depression, ensuring precise target engagement for effective treatment.

Discover how deep brain stimulation, a breakthrough treatment, offers hope for patients with treatment-resistant depression.

Peter J. Weiden, MD, discusses the latest Cobenfy data and implications for schizophrenia treatment.

"That life is real and if you can survive it, well, survive it well with love and art and meaning given where meaning’s scarce."

Wisdom: in the eyes of the beholder?

Here are 3 simple steps to help reduce physician suicide.

Gus Alva, MD, discusses how he will be examining notable challenges in schizophrenia care, including access issues, and exploring the potential role of prescription digital therapeutics in addressing these gaps.

Physicians are less likely to get treatment for physical and mental issues, which may be driving higher rates of suicide.

Research has found a higher rate of female physician suicide. One of the investigators shares more details.

"All morning I did the work I love. At noon I lay down with my mate. It might have been otherwise."

What are the psychological implications of Passover?

Different medications for different domains: new treatments are changing the way schizophrenia is managed.

Here's what patients should know about Cobenfy for the treatment of schizophrenia.

Without the scaffolding of the REMS requirement for clozapine, how can you best utilize this treatment?

How can you best transition patients to Cobenfy if they are already taking an antipsychotic medication?

"$240. 47-year-old insurance salesman, depressed, alcoholic came in eight times, once with his wife."

Psychiatrists and nutritionists can work together to generate better outcomes for patients.

Addressing complex eating disorders can be difficult. Here are a few things to ease the process.

Advocacy may put us at odds with others, but we must prioritize good ethics for our patients. It's time to think outside the box.

Here are the conversations you should be having with patients about food and diet.

Explore the impact of nutrition on patients with cognitive issues in psychiatry.

In his brand new video series, Frank A. Clark, MD, sits down with an expert to discuss parental leave and how it relates to psychiatry.

"Doctors in their lonely rounds, Poets with their sacred sounds, Human kindness that abounds shout, nothing stops the spring."

How does John Kane, MD, address issues of cognition in schizophrenia?

How can psychiatry avoid foolishness and be more like Shakespeare's fools?

SPG302, a regenerative treatment for schizophrenia, could reset the clock on the brain.

John Kane, MD, believes the removal of the REMS requirement for clozapine could help improve utilization for this "grossly underutilized" drug.

Treatments that target negative and cognitive symptoms of schizophrenia could put patients in better control of their life.